Physicians Financial Services’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $655K | Sell |
6,730
-200
| -3% | -$19.5K | 0.2% | 76 |
|
|
2025
Q1 | $504K | Sell |
6,930
-100
| -1% | -$7.27K | 0.16% | 84 |
|
|
2024
Q4 | $508K | Buy |
+7,030
| New | +$508K | 0.15% | 83 |
|
|
2024
Q3 | – | Sell |
-6,930
| Closed | -$738K | – | 111 |
|
|
2024
Q2 | $738K | Hold |
6,930
| – | – | 0.24% | 68 |
|
|
2024
Q1 | $673K | Hold |
6,930
| – | – | 0.24% | 73 |
|
|
2023
Q4 | $543K | Hold |
6,930
| – | – | 0.21% | 79 |
|
|
2023
Q3 | $434K | Hold |
6,930
| – | – | 0.18% | 86 |
|
|
2023
Q2 | $446K | Hold |
6,930
| – | – | 0.18% | 88 |
|
|
2023
Q1 | $367K | Buy |
6,930
+100
| +1% | +$5.3K | 0.16% | 89 |
|
|
2022
Q4 | $287K | Hold |
6,830
| – | – | 0.13% | 97 |
|
|
2022
Q3 | $250K | Buy |
6,830
+1,520
| +29% | +$55.6K | 0.12% | 99 |
|
|
2022
Q2 | $226K | Buy |
5,310
+30
| +0.6% | +$1.28K | 0.1% | 106 |
|
|
2022
Q1 | $284K | Buy |
5,280
+80
| +2% | +$4.3K | 0.11% | 104 |
|
|
2021
Q4 | $374K | Hold |
5,200
| – | – | 0.14% | 96 |
|
|
2021
Q3 | $296K | Buy |
5,200
+500
| +11% | +$28.5K | 0.12% | 104 |
|
|
2021
Q2 | $306K | Hold |
4,700
| – | – | 0.13% | 100 |
|
|
2021
Q1 | $280K | Buy |
+4,700
| New | +$280K | 0.12% | 101 |
|
|
2020
Q3 | – | Sell |
-6,200
| Closed | -$201K | – | 107 |
|
|
2020
Q2 | $201K | Buy |
+6,200
| New | +$201K | 0.11% | 106 |
|